Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment

NCT06081595 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Ovarian Cancer

Interventions

DRUG: Fluzoparib
DRUG: Apatinib

Sponsor

Jin Li